Product
OPL-0401
Aliases
OPL-0401 Dose 1
1 clinical trial
2 indications
Indication
Nonproliferative Diabetic RetinopathyIndication
Diabetic RetinopathyClinical trial
Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic RetinopathyStatus: Recruiting, Estimated PCD: 2024-07-01